Strides Pharma gets USFDA nod for generic drug

Bengaluru-based Strides Pharma has 127 cumulative abbreviated new drug applications (ANDA) filings with USFDA of which 96 have been approved and 31 are pending approval.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news